Medical supply chain business is highly recognized by the board of directors

On March 19, 2019, the board of directors of BDHI held a meeting in Shanghai, China. Dan Morissette, Chief Financial Officer of Dignity Health Group, participated as an invited leader. The meeting mainly considered and adopted the company's work plan for 2019.The directors who attended the meeting highly recognized the company's vigorous development of the medical supply chain business. They agreed that the company's advantages lie in exporting high-quality products certified by the United States FDA to all parts of the world, including the United States, by integrating the production resources of Chinese medical devices and consumables. As the largest medical service group in the United States, Common Spirit Health's huge procurement needs can provide a very strong impetus for the company's rapid development. We believe that the company also has the ability to serve more international medical groups or hospitals. The meeting demanded that the company should strictly examine the selection conditions of cooperative enterprises, take product quality control and compliance as the most important consideration index, and ensure product quality stability and traceability. The cooperative production enterprises should not only meet the requirements of FDA standards, but also accept the whole process quality control by our company's resident personnel. Dan, the group's chief financial officer, said he would fully support the company's business development and encourage the company to expand the medical supply chain market. He hoped that the company would be listed in few years.